Finally, NR2F1 was able to directly bind the promoter region of MMP2, MMP9 and VE-cadherin, transcriptionally promoting the expression of VM-associated proteins, which in turn promoted VM formation in GBM. The gene discussed is MMP9; the disease is glioblastoma.